Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Lab On-Chip and Microarrays Market : By Product Type Microarrays ), By End User and Geography
Lab On-Chip and Microarrays Market : By Product Type Microarrays ), By End User and Geography
Lab On-Chip And Microarrays Market size was valued at US$ 17.32 billion in 2023 and is poised to grow at a significant CAGR of 13.6% from 2024-2030. Lab on the chip an evolutionary device which integrates single or many laboratory functions on one integrated circuit commonly, a cSizhip. Lab-on-chip generally measures about few square centimetres and used to achieve automation and high through screening. The microarray is the most recent advances in the cancer research.
Microarrays help to analyse plenty of samples which have already been recorded or new samples, it even helps to test the incidence of a particular marker in tutors. There are two types of microarrays, gene expression microarrays and tissue microarrays. The market has very few and dominant players who are actively participating in research and development of the new products. Companies are launching the new products to increase the market share.
Study Period
2024-2030Base Year
2023CAGR
13.6%Largest Market
North AmericaFastest Growing Market
Europe
Global lab on chip and microarrays market is mainly driven by the increase in the adaptation of lab on chip and microarrays in various research fields such as drug discovery, genomics, proteomics and others. In addition, increase in demand for personalized medicine and increase in prevalence rates of cancer that led to the demand for the development of R&D related to cancer diagnostics and treatment expected to boost the global market over the forecast period. However, a high cost of devices and stringent regulations for research on genomes are expected to hamper the market growth over the forecast period.
Geographically global Lab On-Chip and Microarrays is segmented as Latin America, Europe, Asia- Pacific, North America, and the Middle East & Africa. North America expected to contribute major growth in global lab-on-chip and microarrays market owing to increase in research and development activities related to cancer and gene sequencing technologies and increase in an adaptation of microarray and lab-on-chip products for diagnosis. Europe is expected to be another major market owing to rising cancer prevalence that leading to the need for the development of reliable and fast diagnostics. Asia Pacific is expected to grow at significant rates owing to the low cost of raw materials and developing healthcare infrastructure.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 17.32 billion |
|
Market CAGR |
13.6% |
|
By Product Type |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The global lab on chip and microarrays market size was valued at US$ 17.32 billion in 2023 and is projected to grow at a CAGR of 13.6% from 2024 to 2030.
The key segments covered in the lab on-chip and microarrays market are technology, components, application, and end-users.
The Lab on-chip and microarrays market key players are Affymetrix Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies (U.S.), Biomerieux SA (France), Beckman Coulter Inc. (U.S.), CombiMatrix Molecular Diagnostics (CombiMatrix Corp.) (U.S.)
| 1.Executive Summary |
| 2.Global Lab On-Chip And Microarrays Market Introduction |
| 2.1.Global Lab On-Chip And Microarrays Market - Taxonomy |
| 2.2.Global Lab On-Chip And Microarrays Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.End User |
| 2.2.3.Region |
| 3.Global Lab On-Chip And Microarrays Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Lab On-Chip And Microarrays Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Lab On-Chip And Microarrays Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Lab-On-A-Chips |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Microarrays |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Lab On-Chip And Microarrays Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Biotechnology and Pharmaceutical Firms |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Academic and Research Institutions |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Hospitals and Diagnostic Centres |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Lab On-Chip And Microarrays Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Lab On-Chip And Microarrays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Lab-On-A-Chips |
| 8.1.2.Microarrays |
| 8.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Biotechnology and Pharmaceutical Firms |
| 8.2.2.Academic and Research Institutions |
| 8.2.3.Hospitals and Diagnostic Centres |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Lab On-Chip And Microarrays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Lab-On-A-Chips |
| 9.1.2.Microarrays |
| 9.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Biotechnology and Pharmaceutical Firms |
| 9.2.2.Academic and Research Institutions |
| 9.2.3.Hospitals and Diagnostic Centres |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10.Asia Pacific (APAC) Lab On-Chip And Microarrays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Lab-On-A-Chips |
| 10.1.2.Microarrays |
| 10.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Biotechnology and Pharmaceutical Firms |
| 10.2.2.Academic and Research Institutions |
| 10.2.3.Hospitals and Diagnostic Centres |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Lab On-Chip And Microarrays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Lab-On-A-Chips |
| 11.1.2.Microarrays |
| 11.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Biotechnology and Pharmaceutical Firms |
| 11.2.2.Academic and Research Institutions |
| 11.2.3.Hospitals and Diagnostic Centres |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Lab On-Chip And Microarrays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Lab-On-A-Chips |
| 12.1.2.Microarrays |
| 12.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Biotechnology and Pharmaceutical Firms |
| 12.2.2.Academic and Research Institutions |
| 12.2.3.Hospitals and Diagnostic Centres |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Affymetrix Inc. (U.S) |
| 13.2.2.Abbott Laboratories (U.S) |
| 13.2.3.Agilent Technologies (U.S) |
| 13.2.4.Biomerieux SA (France) |
| 13.2.5.Beckman Coulter Inc. (U.S) |
| 13.2.6.CombiMatrix Molecular Diagnostics (CombiMatrix Corp) (U.S) |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.